Christopher Peetz sold $3.8M of Mirum Pharmaceuticals (MIRM)

Executed Mar 16, disclosed Mar 17, 1 day later.

Value, as filed

$3.8M

40,985 sh × $91.98

Executed

Mar 16

the trade date, as filed

Disclosed

Mar 17

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Christopher Peetz CHIEF EXECUTIVE OFFICER profile →

Christopher Peetz (CHIEF EXECUTIVE OFFICER) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $3.8M of MIRM (40,985 sh × $91.98, as filed), executed Mar 16.

The name

MIRM

Mirum Pharmaceuticals, Inc. MIRM · Healthcare · 60 filings in 24 months ticker →

Healthcare · Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitat…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher Peetz in MIRM

MIRMSALE Mirum Pharmaceuticals, Inc. $3.0M
30,000 sh across 2 lots
Exec Sep 1
Filed Sep 3 · 6:52 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $2.0M
20,000 sh across 3 lots
Exec Aug 10
Filed Aug 11 · 5:41 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $2.4M
20,000 sh across 4 lots
Exec Jul 6
Filed Jul 8 · 5:12 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $2.8M
29,117 sh across 5 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $941K
9,108 sh × $103.30
Exec Feb 2
Filed Feb 3 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $657K
6,831 sh × $96.19
Exec Jan 26
Filed Jan 27 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $662K
7,098 sh × $93.33
Exec Jan 22
Filed Jan 23 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $2.5M
40,000 sh × $62.00
Exec Aug 11 2025
Filed Aug 12 2025 · 5:30 PM ET